LRMR
Larimar Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.60
-0.17 ▼ -3.56%
🌙 3월 13일 6:50 PM ET (한국 3/14 07:50)
$4.79
+0.20 ▲ +4.24%
| Index | RUT | P/E | - | EPS (ttm) | -1.93 | Insider Own | 45.67% | Shs Outstand | 0.09B | Perf Week | -11.88% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | 6.15% | Insider Trans | 11.82% | Shs Float | 0.05B | Perf Month | 37.72% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | -0.49 | Inst Own | 41.43% | Short Float | 16.54% | Perf Quarter | 16.75% |
| Income | -0.13B | P/S | - | EPS this Y | -47.85% | Inst Trans | -12.04% | Short Ratio | 1.89 | Perf Half Y | 10.31% |
| Sales | 0.00B | P/B | 2.83 | EPS next 5Y | -0.62% | ROA | -64.96% | Short Interest | 7.69M | Perf YTD | 20.73% |
| Book/sh | 1.62 | P/C | 2.77 | EPS past 3/5Y | 23.6% 50.78% | ROE | -78.24% | 52W High | -28.35% ($6.42) | Perf Year | 76.25% |
| Cash/sh | 1.66 | P/FCF | - | Sales past 3/5Y | - | ROIC | -92.8% | 52W Low | 185.71% ($1.61) | Perf 3Y | -19.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -67.41% | Gross Margin | - | Volatility(W/M) | 10.66% 11.9% | Perf 5Y | -74.14% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.48 | Perf 10Y | -93.54% |
| Dividend Ex-Date | - | Quick Ratio | 4.06 | EPS Q/Q | -150.8% | Profit Margin | - | RSI (14) | 50.99 | Recom | 1.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.06 | Sales Q/Q | - | SMA20 | 0.87% ($4.56) | Beta | 0.99 | Target Price | $16.6 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 11000000 | SMA50 | 18.94% ($3.87) | Rel Volume | 0.94 | Prev Close | $4.77 |
| Employees | 65 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | -51.1% - | SMA200 | 24.29% ($3.7) | Avg Volume(3M) | 4.08M | Price | $4.6 |
| IPO | 2014/6/19 | Option/Short | Yes/Yes | Trades | 12466 | Volume | 3,841,977 | Change | -3.56% |
뉴스 로딩 중...